Wells Fargo & Company P Lx Pharma Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.3 $78 - $195	-651 Reduced 7.91%	7,577 $0
Q4 2022 Feb 13, 2023	BUY	$0.15 - $0.63 $2 - $8	14 Added 0.17%	8,228 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.52 - $3.08 $2,130 - $12,618	4,097 Added 99.51%	8,214 $6,000
Q2 2022 Aug 12, 2022	BUY	$1.9 - $4.18 $2,114 - $4,652	1,113 Added 37.05%	4,117 $10,000
Q1 2022 May 16, 2022	BUY	$3.54 - $8.3 $2,127 - $4,988	601 Added 25.01%	3,004 $12,000

Q4 2021 Feb 14, 2022	BUY	$7.69 - $19.66 $792 - $2,024	103 Added 4.48%	2,403 $19,000
Q3 2021 Nov 15, 2021	BUY	$12.22 - $21.28 $9,201 - $16,023	753 Added 48.67%	2,300 $45,000
Q2 2021 Aug 16, 2021	BUY	$9.0 - $15.94 $54 - $95	6 Added 0.39%	1,547 $21,000
Q1 2021 May 13, 2021	BUY	$5.24 - $10.14 $5,664 - $10,961	1,081 Added 235.0%	1,541 $14,000
Q4 2020 Feb 09, 2021	BUY	$3.01 - $6.7 $614 - $1,366	204 Added 79.69%	460 $2,000
Q3 2020 Nov 05, 2020	BUY	$2.83 - $4.21 $16 - $25	6 Added 2.4%	256 $1,000
Q1 2020 May 14, 2020	BUY	$1.98 - $5.87 $495 - $1,467	250 New	250 $0

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.